M. Widersten et al.
ing new mutations at position A (F33) and C (V141, L145, I155).
The enzyme variant [V141K, I155V] from library C was used as the
template for introducing mutations at position 33 and at posi-
tions 106 and 109. The enzyme variant [F189V] was used as the
template for introducing mutations at positions A (F33), B (W106,
L109), and C (V141, L145, I155). For a schematic view of the paths
taken during library construction see Figure 2.
A well giving rise to a low absorbance value combined with a col-
orless well in both duplicate plates was scored as a hit.
Protein expression and purification of hits: Expression plasmids
encoding mutant variants of StEH1–5H were transformed into
E. coli XL1-Blue bacteria by electroporation. An overnight culture
(
5 mL) of 2TY medium [tryptone (1%, w/v), yeast extract (1.6%, w/
ꢀ
1
v), NaCl (0.5%, w/v)] containing ampicillin (100 mgmL ), inoculated
with a single bacteria colony grown at 308C (200 rpm), was used
to start a culture of 2TY media (0.5 L) fortified with ampicillin
Protein expression for screening: All procedures were performed
under sterile conditions in 96-well microtiter plates (Nunc, poly-
propylene, round-bottomed, accommodating at least 400 mL).
Expression plasmids encoding mutant variants of StEH1–5H were
transformed into E. coli XL1-Blue bacteria by electroporation with
the aid of a Bio-Rad Gene Pulser. The bacteria were plated on agar
ꢀ1
(50 mgmL ). The culture was grown at 308C (200 rpm) until the
optical density at 600 nm reached 0.3. Isopropyl b-d-thiogalacto-
pyranoside (final concentration 1 mm) was then added to induce
protein expression. The culture was grown for 18 h and the cells
were collected by centrifugation at 5000 g for 12 min and then
resuspended in buffer [sodium phosphate (pH 7.0, 10 mm) and
sodium azide (0.02%, w/v)] with added protease inhibitor (Com-
plete Protease Inhibitor Cocktail Tablets EDTA-free, Roche). The
bacterial resuspension was then ultrasonicated with a Vibra Cell
Sonifier (power setting 7.5) for five pulses of 30 s with more than
one minute cooling time in between. The suspension was centri-
fuged for 45 min at 30000g and the supernatant, containing the
enzyme of interest, was filtered through a 0.2 mm filter with a glass
pre-filter (Pall Life Science). The lysate was then directly applied
ꢀ
1
plates (ampicillin, 100 mgmL ). From these plates single colonies
were picked and inoculated into wells containing 2TY medium
[
3
tryptone (1%, w/v), yeast extract (1.6%, w/v), NaCl (0.5%, w/v),
50 mL] containing ampicillin (100 mgmL ). Four wells were left
ꢀ
1
uninoculated and four were inoculated with wild-type StEH1 for
reference reasons. The plates were covered with gas-permeable
adhesive seal film and incubated overnight at 308C (200 rpm).
After 18 h incubation, overnight culture (25 mL) from each well was
used to inoculate a new well on a new plate with fresh 2TY media
ꢀ
1
fortified with ampicillin (50 mgmL ). The bacteria were grown for
h (308C, 200 rpm), after which isopropyl b-d-thiogalactopyrano-
II
3
onto a HisTrap HP 1 mL column preloaded with Ni ions and equili-
side was added (final concentration 1 mm) to induce protein
expression (glycerol was added to the wells of the plate with the
overnight cultures to a final concentration of 15%; the plate was
stored in ꢀ808C for later recovery of screening hits). After 18 h of
incubation, the plate was centrifuged (48C, 3500 rpm) for 20 min.
The supernatant was removed and the bacteria pellet was resus-
pended in sodium phosphate, (0.1m, pH 7.0) with added protease
inhibitor (Complete Protease Inhibitor Cocktail Tablets EDTA-free
from Roche) and stored at ꢀ808C until screened.
brated with imidazole-containing buffer [imidazole (20 mm), NaCl
(0.5m), sodium phosphate (10 mm), pH 7.0]. Loosely bound pro-
teins were washed off by use of an increase in imidazole concen-
tration to 100 mm. Tightly bound proteins were eluted with the
same buffer fortified with imidazole (300 mm). The enzyme-con-
taining fractions from the last elution step were pooled and the
buffer was changed to sodium phosphate (0.1m, pH 7.4) with the
aid of a PD-10 column. The homogeneities of purified protein sam-
ples were determined by SDS-PAGE stained with Coomassie Bril-
liant Blue R-250 and the enzyme was established to be at least
Activity screening: Buffer was added to the frozen bacteria pellets
9
5% pure. Protein concentrations of collected fractions were deter-
[
1
(
final concentrations in the wells: sodium phosphate (pH 7.0,
mined from the absorbance values at 280 nm. The molar absorb-
ance coefficient used, calculated from the amino acid composition,
ꢀ
1
0 mm), lysozyme (0.2 mgmL ),
MgCl2
(5 mm), DNaseI
ꢀ
1
0.2 mgmL )]. The pellets were thawed at room temperature and
ꢀ1
ꢀ1
was 59030m cm both for wild-type StEH1 and for mutant var-
were then incubated at 48C for 1 h, after which four freeze/thaw-
ing cycles were performed (16 min at ꢀ808C, followed by 20 min
incubation at 308C). The plate was then centrifuged at 3500 rpm
for 60 min, after which an aliquot (25 mL) of lysate from each well
was transferred to a corresponding microtiter plate (polystyrene,
iants. The coefficient was recalculated and used according to the
formula (nWꢂ5500)+(nYꢂ1490)+(nCꢂ125), where
n is the
number of the specific amino acid residue, if the enzyme had lost
or gained any tryptophan, tyrosine, or cysteine residues. The calcu-
lated molecular weight used was 37.1 kDa. Around 5–20 mg of
purified enzyme per liter of culture was obtained. All preparations
were made at 48C starting from the centrifugation of the bacteria
and the enzyme was stored in the fridge with retention of full
activity during the timespan of the experimental data collection.
9
6 wells, flat-bottomed, Nunc). This was done in duplicate for each
plate. The following screening protocol is adapted from ref. [32].
The substrate 1 was dissolved in sodium phosphate [0.1m, pH 7.0,
containing dimethyl sulfoxide (10%, v/v)]. For the screening of the
first-generation libraries the racemic mixture of 1 was used. In the
screening of the second-generation libraries the pure enantiomers
were used. Equal volumes of lysate and substrate were mixed, re-
sulting in a final concentration of 1 of 5 mm. The enzyme was incu-
bated with the substrate with agitation for 10 min at 308C, after
which the epoxide hydrolase reaction was stopped by addition of
Enantioselectivities of purified enzyme variants: The diol product
distribution after epoxide-hydrolase-catalyzed hydrolysis of rac-1
was established with purified enzyme variants and separation of
diols by chiral HPLC. Purified enzyme (0.5 mm) was mixed with rac-
1 (30 mm) in sodium phosphate (0.1 mm, pH 7.0), containing a
final concentration of 3%, (v/v) acetonitrile. The reaction mixture
was incubated at 308C (200 rpm) for five minutes, after which
methanol (50% final concentration) was added to stop the reac-
tion. The solvents were then evaporated and the residual analytes
were dissolved in hexane/isopropanol (80:20, v/v). The separation
of the formed diols was performed by injection of the analytes
with the aid of a Shimadzu SIL-10AF autosampler over a Daicel
Chiralpak AS-H (250ꢂ4.6 mm ID) column with a Shimadzu Promi-
2
-(4-nitrobenzyl)-pyridine (25 mL of 100 mm dissolved in ethylene
glycol/ethanol 80:20, v/v). The plate was incubated for 20 min at
08C, after which ethanol (50 mL, 95%) and potassium carbonate
1m, 25 mL) were added. A blue colored conjugate forms in the
8
(
wells if epoxide is still present, whereas a colorless well indicates
total conversion of epoxide into diol. The absorbance from the de-
veloped color was measured directly at 570 nm with a microtiter-
plate reader spectrophotometer (SpectraMax190, Molecular Devi-
ces). Manual visual identification of hits was also performed, due
to precipitation in some of the wells giving rise to false negatives.
ꢀ1
nence LC-20AD pump and a flow rate of 0.5 mLmin . The mobile
phase consisted of hexane/isopropanol (95:5, v/v). Peaks were de-
1
428
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemBioChem 2010, 11, 1422 – 1429